{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:41:28Z","timestamp":1791096088052,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1016\/j.jaut.2005.09.005","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:22:50Z","timestamp":1130484170000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"S","title":["Redefining the HLA and RA association: To be or not to be anti-CCP positive"],"prefix":"10.1016","volume":"25","author":[{"given":"Ren\u00e9 R.P.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2005.09.005_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1399-0004.1989.tb03185.x","article-title":"The contribution of HLA to rheumatoid arthritis","volume":"36","author":"Deighton","year":"1989","journal-title":"Clin Genet"},{"key":"10.1016\/j.jaut.2005.09.005_bib3","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1172\/JCI108382","article-title":"Mixed lymphocyte cultures in rheumatoid arthritis","volume":"57","author":"Stastny","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2005.09.005_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/art.1780340107","article-title":"Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the \u201cshared epitope\u201d hypothesis","volume":"34","author":"Willkens","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1399-0039.1990.tb01825.x","article-title":"HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population","volume":"36","author":"Sanchez","year":"1990","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2005.09.005_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/ard.50.5.295","article-title":"Is rheumatoid arthritis in Indians associated with HLA antigens sharing a DR beta 1 epitope?","volume":"50","author":"Ollier","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2005.09.005_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0167-5699(95)80181-2","article-title":"Could HLA-DRB1 be the protective locus in rheumatoid arthritis?","volume":"16","author":"Zanelli","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaut.2005.09.005_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s002510050450","article-title":"An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition","volume":"48","author":"Zanelli","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaut.2005.09.005_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0198-8859(98)00101-3","article-title":"HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis","volume":"60","author":"van der Horst-Bruinsma","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2005.09.005_bib11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","article-title":"CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis","volume":"48","author":"Morgan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00541373","article-title":"HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritis","volume":"6","author":"Silman","year":"1986","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2005.09.005_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.1780340707","article-title":"Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study","volume":"34","author":"van Zeben","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.10151","article-title":"Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage","volume":"46","author":"Lard","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib15","first-page":"715","article-title":"Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis","volume":"53","author":"Dizier","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaut.2005.09.005_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z","article-title":"Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis","volume":"44","author":"Reviron","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/ard.2003.009969","article-title":"HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis","volume":"63","author":"Laivoranta-Nyman","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2005.09.005_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/ard.46.5.395","article-title":"HLA haplotypes in non-familial rheumatoid arthritis","volume":"46","author":"Legrand","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2005.09.005_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2005.09.005_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0198-8859(00)00227-5","article-title":"The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci","volume":"62","author":"Zanelli","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2005.09.005_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cair.2003.11.001","article-title":"Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis","volume":"4","author":"Vossenaar","year":"2004","journal-title":"Clin Appl Immunol Rev"},{"key":"10.1016\/j.jaut.2005.09.005_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib23","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib24","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2005.09.005_bib27","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/art.21272","article-title":"An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility","volume":"9","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2005.09.005_bib28","unstructured":"Huizinga TWJ, Amos CI, van der Helm-van Mil AHM, Chen W, van Gaalen FA, Jawaheer D, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to cirullinated proteins. Arthritis Rheum, in press."},{"key":"10.1016\/j.jaut.2005.09.005_bib29","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis","volume":"10","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841105001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841105001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:56:24Z","timestamp":1760255784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841105001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":29,"alternative-id":["S0896841105001125"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2005.09.005","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining the HLA and RA association: To be or not to be anti-CCP positive","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2005.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}